Uncompetitive Inhibition
Enzymes & Metabolic Pathway Regulation
Uncompetitive Inhibition in the simple model binds inhibitor to enzyme–substrate complex.
In simple reversible models, competitive inhibition raises apparent Km while preserving Vmax; pure noncompetitive inhibition lowers Vmax without changing Km. Uncompetitive inhibition lowers both, while mixed inhibition lowers Vmax and can shift Km in either direction. These are assumption-dependent patterns, not synonyms for any allosteric binding. Real data require testing, and an inhibitor's binding location alone cannot assign its complete kinetic category.
An inhibitor may act reversibly or persistently; a short-term activity decrease does not establish irreversibility. Product inhibition, excess-substrate inhibition and pathway end-product feedback are distinct. A test-tube effective concentration is not necessarily achievable in human tissue by eating a substance. Detecting inhibition therefore does not automatically justify a dietary recommendation or avoidance, nor demonstrate sports benefit or harm without exposure and outcome evidence.
Allosteric regulation changes activity through communication between regulatory binding and functional regions; it can activate or inhibit. Feedback carries downstream-product or state information upstream, whereas feedforward conveys input or upstream information onward. Both can operate in one network. Regulation coordinates supply and use rather than keeping every enzyme maximally active, so more activation is not automatically a better nutritional or training outcome.
For example, after training changes an enzyme result, first ask whether it was measured in blood, tissue or purified protein. Then assess assay conditions, nutrition and time since the last session alongside actual performance; this comparison helps distinguish a regulatory response from a nutritional deficiency or a presumed supplement need.
🔒 The rest of this entry is available after free Google sign-in.
Home
Academy
Site Map